<code id='4BDD3A4871'></code><style id='4BDD3A4871'></style>
    • <acronym id='4BDD3A4871'></acronym>
      <center id='4BDD3A4871'><center id='4BDD3A4871'><tfoot id='4BDD3A4871'></tfoot></center><abbr id='4BDD3A4871'><dir id='4BDD3A4871'><tfoot id='4BDD3A4871'></tfoot><noframes id='4BDD3A4871'>

    • <optgroup id='4BDD3A4871'><strike id='4BDD3A4871'><sup id='4BDD3A4871'></sup></strike><code id='4BDD3A4871'></code></optgroup>
        1. <b id='4BDD3A4871'><label id='4BDD3A4871'><select id='4BDD3A4871'><dt id='4BDD3A4871'><span id='4BDD3A4871'></span></dt></select></label></b><u id='4BDD3A4871'></u>
          <i id='4BDD3A4871'><strike id='4BDD3A4871'><tt id='4BDD3A4871'><pre id='4BDD3A4871'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          explore

          author:leisure time    - browse:48156
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time